sub:assertion {
<
http://purl.obolibrary.org/obo/DOID_8691>
bl:category bl:Disease .
sub:association rdf:object <
http://purl.obolibrary.org/obo/DOID_8691> ;
rdf:predicate bl:treats ;
rdf:subject <
https://identifiers.org/drugbank:DB00563> ;
a rdf:Statement ;
rdfs:label "methotrexate is indicated in the treatment of gestational choriocarcinoma chorioadenoma destruens and hydatidiform mole in acute lymphocytic leukemia methotrexate is indicated in the prophylaxis of meningeal leukemia and is used in maintenance therapy in combination with other chemotherapeutic agents methotrexate is also indicated in the treatment of meningeal leukemia methotrexate is used alone or in combination with other anticancer agents in the treatment of breast cancer epidermoid cancers of the head and neck advanced mycosis fungoides cutaneous t cell lymphoma and lung cancer particularly squamous cell and small cell types methotrexate is also used in combination with other chemotherapeutic agents in the treatment of advanced stage non hodgkin s lymphomas methotrexate in high doses followed by leucovorin rescue in combination with other chemotherapeutic agents is effective in prolonging relapse free survival in patients with non metastatic osteosarcoma who have undergone surgical resection or amputation for the primary tumor methotrexate is indicated in the symptomatic control of severe recalcitrant disabling psoriasis that is not adequately responsive to other forms of therapy but only when the diagnosis has been established as by a biopsy and or after dermatologic consultation methotrexate is indicated in the management of selected adults with severe active rheumatoid arthritis acr criteria or children with active polyarticular course juvenile rheumatoid arthritis who have had an insufficient therapeutic response to or are intolerant of an adequate trial of first line therapy including full dose non steroidal anti inflammatory agents nsaids aspirin nsaids and or low dose steroids may be continued although the possibility of increased toxicity with concomitant use of nsaids including salicylates has not been fully explored see precautions drug interactions" ;
bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation ;
bl:provided_by <
https://w3id.org/um/NeuroDKG> ;
bl:relation schema:TreatmentIndication .
<
https://identifiers.org/drugbank:DB00563>
bl:category bl:Drug .
}